Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease

Published:2019-07 Issue:1 Volume:96 Page:159-169
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Gansevoort Ron T.,van Gastel Maatje D.A.,Chapman Arlene B.,Blais Jaime D.,Czerwiec Frank S.,Higashihara Eiji,Lee Jennifer,Ouyang John,Perrone Ronald D.,Stade Katrin,Torres Vicente E.,Devuyst Olivier

Publisher

Elsevier BV

Subject

Nephrology

Reference42 articles.

1. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease;Gabow;Kidney Int,1992

2. Tolvaptan in patients with autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2012

3. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA working groups on inherited kidney disorders and european renal best practice;Gansevoort;Nephrol Dial Transplant,2016

4. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials;Irazabal;J Am Soc Nephrol,2015

5. Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease;Devuyst;Curr Opin Nephrol Hypertens,2013

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study;American Journal of Kidney Diseases;2024-09

2. Visceral Adiposity and Progression of ADPKD: A Cohort Study of Patients From the TEMPO 3:4 Trial;American Journal of Kidney Diseases;2024-09

3. Visceral Abdominal Adiposity and Autosomal Dominant Polycystic Kidney Disease Progression: One More Step Toward Identifying Useful Biomarkers and Characterizing the Disease Metabolic Links;American Journal of Kidney Diseases;2024-09

4. The Impact of Autosomal Dominant Polycystic Kidney Disease in Children: A Nephrological, Nutritional, and Psychological Point of View;Biomedicines;2024-08-12

5. Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications;Critical Reviews in Clinical Laboratory Sciences;2024-07-31